Literature DB >> 12604095

A role for COX-2 and p38 mitogen activated protein kinase in long-term depression in the rat dentate gyrus in vitro.

H J Murray1, J J O'Connor.   

Abstract

Long-term potentiation (LTP) and long-term depression (LTD) are two forms of activity-dependent synaptic plasticity that are thought to be involved in learning and memory. Evidence has shown that cyclooxygenase-2 (COX-2), an enzyme that converts arachidonic acid to prostaglandins, is expressed in postsynaptic dendritic spines and is regulated by synaptic activity. COX-2 inhibition has been shown to directly attenuate LTP in the dentate gyrus of the hippocampus. Also recently the p38 MAP kinase cascade, a pathway utilised by cells for COX-2 expression, has been implicated in LTD induction in the CA1 region of the hippocampus. Here we demonstrate for the first time a direct role for COX-2 and p38 MAP kinase in LTD and confirm the inhibitory role of COX-2 in LTP in the rat dentate gyrus. Perfusion of the COX-2 inhibitor NS-398 (1 micro M) 60 min before tetanic stimulation resulted in an attenuation of LTD (84+/-5%, n=5 compared to controls of 57+/-7%, n=6, P<0.05). Prolonged exposure (2 h) to NS-398 (1 micro M) resulted in a significant reduction in LTP (71+/-8%, n=5, P<0.01 compared to controls of 170+/-11%, n=5 at 60 min post HFS). The p38 MAPK inhibitor, SB220025 (250 nM) significantly attenuated LTD (88+/-5%, n=7; P<0.01 compared to vehicle controls at 60 min, 56+/-5%, n=6) but had no significant effect on LTP. Both NS-398 and SB220025 had no significant effect on the isolated NMDA-mediated EPSP. These data demonstrate a role for COX-2 and p38 MAPK in LTD in the dentate gyrus in vitro that is independent of NMDA receptor activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604095     DOI: 10.1016/s0028-3908(02)00375-1

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  24 in total

1.  Vatairea macrocarpa lectin (VML) induces depressive-like behavior and expression of neuroinflammatory markers in mice.

Authors:  Filipe Marques Gonçalves; Andiara Espíndola Freitas; Tanara Vieira Peres; Débora Kurrle Rieger; Juliana Ben; Mariana Maestri; Ana Paula Costa; Ana Carolina Tramontina; Carlos Alberto Gonçalves; Ana Lúcia Severo Rodrigues; Celso Shiniti Nagano; Edson Holanda Teixeira; Kyria S Nascimento; Benildo Sousa Cavada; Rodrigo Bainy Leal
Journal:  Neurochem Res       Date:  2013-09-12       Impact factor: 3.996

2.  The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.

Authors:  Annamaria Lanzillotta; Ilenia Sarnico; Marina Benarese; Caterina Branca; Cristina Baiguera; Birgit Hutter-Paier; Manfred Windisch; Pierfranco Spano; Bruno Pietro Imbimbo; Marina Pizzi
Journal:  J Mol Neurosci       Date:  2010-12-22       Impact factor: 3.444

3.  Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function.

Authors:  F Hu; X Wang; T W W Pace; H Wu; A H Miller
Journal:  Mol Psychiatry       Date:  2005-05       Impact factor: 15.992

Review 4.  Cyclooxygenase-2 in synaptic signaling.

Authors:  Hongwei Yang; Chu Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

5.  Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor.

Authors:  Hongwei Yang; Jian Zhang; Richard M Breyer; Chu Chen
Journal:  J Neurochem       Date:  2008-11-21       Impact factor: 5.372

6.  Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus.

Authors:  G E Serrano; N Lelutiu; A Rojas; S Cochi; R Shaw; C D Makinson; D Wang; G A FitzGerald; R Dingledine
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

Review 7.  Cyclooxygenase-2 in epilepsy.

Authors:  Asheebo Rojas; Jianxiong Jiang; Thota Ganesh; Myung-Soon Yang; Nadia Lelutiu; Paoula Gueorguieva; Raymond Dingledine
Journal:  Epilepsia       Date:  2013-11-08       Impact factor: 5.864

8.  Spontaneous Glutamatergic Synaptic Activity Regulates Constitutive COX-2 Expression in Neurons: OPPOSING ROLES FOR THE TRANSCRIPTION FACTORS CREB (cAMP RESPONSE ELEMENT BINDING) PROTEIN AND Sp1 (STIMULATORY PROTEIN-1).

Authors:  Sandra J Hewett; Jingxue Shi; Yifan Gong; Krishnan Dhandapani; Carol Pilbeam; James A Hewett
Journal:  J Biol Chem       Date:  2016-11-14       Impact factor: 5.157

9.  Doxorubicin attenuates serotonin-induced long-term synaptic facilitation by phosphorylation of p38 mitogen-activated protein kinase.

Authors:  Rong-Yu Liu; Yili Zhang; Brittany L Coughlin; Leonard J Cleary; John H Byrne
Journal:  J Neurosci       Date:  2014-10-01       Impact factor: 6.167

10.  COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity.

Authors:  Hongwei Yang; Jian Zhang; Katrin Andreasson; Chu Chen
Journal:  Mol Cell Neurosci       Date:  2008-01-26       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.